OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

11053	Companies
242378	Keywords
170674	Articles
130468	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 12/01/2025 at 08:00, 9 months 21 days ago

Oxurion secures a binding EUR 30 million financing facility dedicated to investments in digital and crypto assets
Oxurion NV secures €30 million financing via convertible bonds from Atlas Capital Markets to invest in digital assets like Bitcoin and Ethereum. The strategy aligns with the company's long-term investment policy

Convertible Bonds Bitcoin Digital Assets Finance Oxurion NV
BRIEF

published on 11/25/2025 at 18:05, 9 months 27 days ago

Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Actions Transparency Health Oxurion Atlas Special Opportunities II LLC
PRESS RELEASE

published on 11/25/2025 at 18:00, 9 months 27 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in share ownership. The company specializes in acquiring stakes in European pharmaceutical subcontractors

Transparency Notification Share Ownership Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF

published on 11/20/2025 at 18:05, 10 months 2 days ago

Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Digital Assets Transparency Notification Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 11/20/2025 at 18:00, 10 months 2 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding percentage due to sale of voting securities

Transparency Notification Oxurion NV Voting Securities Atlas Special Opportunities II, LLC Shareholding Percentage
BRIEF

published on 11/03/2025 at 18:05, 10 months 19 days ago

Oxurion Concludes Preclinical Discussions, Focuses on Strategic Clinical Integration

Strategic Acquisition Oxurion Clinical Integration Pharmaceutical Subcontractors Preclinical Termination
PRESS RELEASE

published on 11/03/2025 at 18:00, 10 months 19 days ago

Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner
Oxurion NV terminates acquisition discussions but moves forward with clinical integration and consolidation strategy. Upholding financial discipline and commitment to high-value services

High-value Services Oxurion NV Consolidation Strategy Clinical Integration Acquisition Termination
BRIEF

published on 10/23/2025 at 18:05, 10 months 30 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion Belgian Regulations
PRESS RELEASE

published on 10/23/2025 at 18:00, 10 months 30 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing. The company specializes in acquiring stakes in European pharmaceutical subcontractors

Transparency Notification Shareholding Threshold Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF

published on 10/17/2025 at 18:05, 11 months 5 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion

Accesswire

Published on 09/23/2026 at 00:00, 23 minutes ago

Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
Published on 09/23/2026 at 00:00, 23 minutes ago

Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
Published on 09/22/2026 at 23:10, 1 hour 13 minutes ago

Global Atomic Announces Proposed Public Offering of Units
Published on 09/22/2026 at 22:30, 1 hour 53 minutes ago

Silver Spruce Receives TSXV Conditional Approval of Debt Settlement
Published on 09/22/2026 at 22:01, 2 hours 22 minutes ago

Fermi and TensorWave Agree to Extend Closing Date to October 31, 2026

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 19:40, 4 hours 42 minutes ago

EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 5 hours 23 minutes ago

LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:30, 5 hours 53 minutes ago

Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 17:45, 6 hours 38 minutes ago

Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform.
Published on 09/22/2026 at 17:40, 6 hours 43 minutes ago

VALBIOTIS SA: Valbiotis announces positive results from the Cardio-Liver clinical study - Commercial launch of ValbiotisPRO® Foie on September 23

Les Echos

Published on 09/22/2026 at 18:10, 6 hours 13 minutes ago

Financial statements - 30 june 2026
Published on 09/22/2026 at 18:00, 6 hours 23 minutes ago

Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 6 hours 38 minutes ago

Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/21/2026 at 18:19, 1 day 6 hours ago

Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 1 day 6 hours ago

Partnership agreement signed between Manitou Group and HD Construction Equipment

View all LES ECHOS COMFI WIRE